Nextgen Healthcare, Inc. (NXGN)

$23.67

+0.01

(+0.04%)▲

Market is closed - opens 7 PM, 21 Sep 2023

Insights on Nextgen Healthcare, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 178.55M → 178.20M (in $), with an average decrease of 0.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -25.24M → 6.15M (in $), with an average increase of 510.0% per quarter

  • Vs TXG

    In the last 1 year, 10x Genomics Inc has given 53.9% return, outperforming this stock by 14.6%

Performance

  • $23.63
    $23.73
    $23.67
    downward going graph

    0.17%

    Downside

    Day's Volatility :0.42%

    Upside

    0.25%

    downward going graph
  • $15.23
    $23.69
    $23.67
    downward going graph

    35.66%

    Downside

    52 Weeks Volatility :35.71%

    Upside

    0.08%

    downward going graph

Returns

PeriodNextgen Healthcare, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
48.31%
0.0%
0.0%
6 Months
34.41%
3.0%
-0.5%
1 Year
39.34%
7.2%
0.4%
3 Years
89.74%
27.5%
19.1%

Highlights

Market Capitalization
1.3B
Book Value
$6.12
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
0.03
PE Ratio
644.33
PEG Ratio
2.56
Wall Street Target Price
20.77
Profit Margin
0.35%
Operating Margin TTM
6.93%
Return On Assets TTM
3.98%
Return On Equity TTM
0.56%
Revenue TTM
678.1M
Revenue Per Share TTM
10.16
Quarterly Revenue Growth YOY
16.2%
Gross Profit TTM
332.8M
EBITDA
56.3M
Diluted Eps TTM
0.03
Quarterly Earnings Growth YOY
4.3
EPS Estimate Current Year
0.96
EPS Estimate Next Year
1.1
EPS Estimate Current Quarter
0.22
EPS Estimate Next Quarter
0.26

Analyst Recommendation

Buy
    53%Buy
    40%Hold
    6%Sell
Based on 15 Wall street analysts offering stock ratings for Nextgen Healthcare, Inc.(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
6
6
6
Sell
1
1
1

Analyst Forecast

What analysts predicted

Downside of 12.25%

Current $23.67
Target $20.77

Company Financials

FY18Y/Y Change
Revenue
531.0M
↑ 4.2%
Net Income
2.4M
↓ 86.73%
Net Profit Margin
0.46%
↓ 3.12%
FY19Y/Y Change
Revenue
529.2M
↓ 0.35%
Net Income
24.5M
↑ 912.15%
Net Profit Margin
4.63%
↑ 4.17%
FY20Y/Y Change
Revenue
540.2M
↑ 2.09%
Net Income
7.5M
↓ 69.39%
Net Profit Margin
1.39%
↓ 3.24%
FY21Y/Y Change
Revenue
556.8M
↑ 3.07%
Net Income
9.5M
↑ 26.9%
Net Profit Margin
1.71%
↑ 0.32%
FY22Y/Y Change
Revenue
596.4M
↑ 7.1%
Net Income
1.6M
↓ 83.0%
Net Profit Margin
0.27%
↓ 1.44%
FY23Y/Y Change
Revenue
653.2M
↑ 9.53%
Net Income
-2.7M
↓ 264.03%
Net Profit Margin
-0.41%
↓ 0.68%
Q1 FY22Q/Q Change
Revenue
151.3M
↑ 1.03%
Net Income
348.0K
↓ 93.3%
Net Profit Margin
0.23%
↓ 3.24%
Q2 FY22Q/Q Change
Revenue
153.3M
↑ 1.35%
Net Income
1.1M
↑ 229.89%
Net Profit Margin
0.75%
↑ 0.52%
Q3 FY22Q/Q Change
Revenue
159.4M
↑ 4.01%
Net Income
13.6M
↑ 1086.67%
Net Profit Margin
8.54%
↑ 7.79%
Q4 FY22Q/Q Change
Revenue
161.9M
↑ 1.53%
Net Income
7.8M
↓ 42.63%
Net Profit Margin
4.83%
↓ 3.71%
Q1 FY23Q/Q Change
Revenue
178.6M
↑ 10.3%
Net Income
-25.2M
↓ 422.97%
Net Profit Margin
-14.14%
↓ 18.97%
Q2 FY23Q/Q Change
Revenue
178.2M
↓ 0.19%
Net Income
6.2M
↓ 124.39%
Net Profit Margin
3.45%
↑ 17.59%
FY18Y/Y Change
Total Assets
515.8M
↑ 8.99%
Total Liabilities
192.3M
↑ 14.37%
FY19Y/Y Change
Total Assets
532.9M
↑ 3.32%
Total Liabilities
156.9M
↓ 18.4%
FY20Y/Y Change
Total Assets
720.1M
↑ 35.13%
Total Liabilities
319.6M
↑ 103.65%
FY21Y/Y Change
Total Assets
644.5M
↓ 10.5%
Total Liabilities
212.8M
↓ 33.41%
FY22Y/Y Change
Total Assets
627.7M
↓ 2.61%
Total Liabilities
204.6M
↓ 3.87%
Q1 FY22Q/Q Change
Total Assets
627.7M
↑ 3.69%
Total Liabilities
204.6M
↑ 5.36%
Q2 FY22Q/Q Change
Total Assets
608.0M
↓ 3.14%
Total Liabilities
179.1M
↓ 12.44%
Q3 FY22Q/Q Change
Total Assets
627.1M
↑ 3.15%
Total Liabilities
185.3M
↑ 3.44%
Q4 FY22Q/Q Change
Total Assets
871.0M
↑ 38.89%
Total Liabilities
453.3M
↑ 144.61%
Q1 FY23Q/Q Change
Total Assets
896.1M
↑ 2.88%
Total Liabilities
495.7M
↑ 9.36%
Q2 FY23Q/Q Change
Total Assets
868.5M
↓ 3.08%
Total Liabilities
457.9M
↓ 7.61%
FY18Y/Y Change
Operating Cash Flow
76.6M
↓ 30.75%
Investing Cash Flow
-91.5M
↑ 702.57%
Financing Cash Flow
6.1M
↓ 106.9%
FY19Y/Y Change
Operating Cash Flow
50.5M
↓ 34.09%
Investing Cash Flow
-25.5M
↓ 72.12%
Financing Cash Flow
-21.6M
↓ 453.78%
FY20Y/Y Change
Operating Cash Flow
85.6M
↑ 69.59%
Investing Cash Flow
-96.1M
↑ 276.41%
Financing Cash Flow
116.3M
↓ 637.08%
FY21Y/Y Change
Operating Cash Flow
98.5M
↑ 15.09%
Investing Cash Flow
-28.5M
↓ 70.29%
Financing Cash Flow
-131.7M
↓ 213.29%
FY22Y/Y Change
Operating Cash Flow
53.5M
↓ 45.65%
Investing Cash Flow
-28.1M
↓ 1.62%
Financing Cash Flow
-37.3M
↓ 71.69%
Q1 FY22Q/Q Change
Operating Cash Flow
16.9M
↑ 4.65%
Investing Cash Flow
-8.2M
↑ 26.74%
Financing Cash Flow
3.7M
↓ 110.02%
Q2 FY22Q/Q Change
Operating Cash Flow
-4.6M
↓ 127.47%
Investing Cash Flow
-9.5M
↑ 15.17%
Financing Cash Flow
-4.1M
↓ 211.07%
Q3 FY22Q/Q Change
Operating Cash Flow
38.4M
↓ 927.58%
Investing Cash Flow
864.0K
↓ 109.14%
Financing Cash Flow
-9.3M
↑ 127.09%
Q4 FY22Q/Q Change
Operating Cash Flow
2.2M
↓ 94.33%
Investing Cash Flow
-56.6M
↓ 6647.8%
Financing Cash Flow
225.5M
↓ 2518.84%

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nextgen Healthcare, Inc.
Nextgen Healthcare, Inc.
46.47%
34.41%
39.34%
89.74%
15.58%
R1 Rcm Inc
R1 Rcm Inc
-4.25%
14.29%
-18.74%
2.89%
66.49%
10x Genomics Inc
10x Genomics Inc
0.41%
-7.17%
50.31%
-62.71%
-13.86%
Veeva Systems Inc.
Veeva Systems Inc.
11.4%
18.3%
25.61%
-22.85%
101.63%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-4.13%
-13.59%
9.31%
9.31%
9.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nextgen Healthcare, Inc.
Nextgen Healthcare, Inc.
644.33
644.33
2.56
0.96
0.01
0.04
0.0
6.12
R1 Rcm Inc
R1 Rcm Inc
128.18
NA
0.77
0.06
-0.02
0.02
0.0
6.55
10x Genomics Inc
10x Genomics Inc
NA
NA
NA
-1.69
-0.22
-0.11
0.0
6.76
Veeva Systems Inc.
Veeva Systems Inc.
64.66
64.66
1.27
4.18
0.15
0.05
0.0
25.85
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
19.51
19.51
NA
3.8
0.15
0.06
0.0
15.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nextgen Healthcare, Inc.
Nextgen Healthcare, Inc.
Buy
$1.3B
15.58%
644.33
0.35%
R1 Rcm Inc
R1 Rcm Inc
Buy
$6.7B
66.49%
128.18
-3.09%
10x Genomics Inc
10x Genomics Inc
Buy
$6.3B
-13.86%
NA
-30.31%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$33.4B
101.63%
64.66
24.2%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$31.5B
9.31%
19.51
9.62%

Institutional Holdings

  • BlackRock Inc

    13.92%

  • Vanguard Group Inc

    9.26%

  • Dimensional Fund Advisors, Inc.

    3.75%

  • State Street Corporation

    3.06%

  • William Blair Investment Management, LLC

    2.93%

  • Capital Research Global Investors

    2.63%

Company Information

nextgen healthcare information systems, llc, a wholly owned subsidiary of quality systems, inc., provides integrated clinical, financial, and connectivity solutions for primary care physicians, specialist physicians, health systems, and dental provider organizations. the company drives collaborative care and patient engagement with a comprehensive suite of products and services that support emerging initiatives such as patient-centered medical home, accountable care organizations, and health information exchange.

Organization
Nextgen Healthcare, Inc.
Employees
2783
CEO
Mr. David William Sides
Industry
Technology Services

Discover More

FAQs